Literature DB >> 20521990

Zingiber officinale protects HaCaT cells and C57BL/6 mice from ultraviolet B-induced inflammation.

Gui-Hee Guahk1, Sang Keun Ha, Hyuk-Sang Jung, Chulhun Kang, Chang-Hyun Kim, Yoon-Bum Kim, Sun Yeou Kim.   

Abstract

Ultraviolet (UV) light is a physical carcinogen, and UV irradiation from sunlight has negative effects on human skin. UVB-induced inflammation is linked to excessive induction of various inflammatory cytokines/chemokines in many types of cells, including keratinocytes. The purpose of this study was to investigate the anti-inflammatory effect of water extract of Zingiber officinale, gingerol, and shogaol on UVB-induced skin damage in the human keratinocyte cell line HaCaT and C57BL/6 mice. To test for an effective compound to protect against inflammation in UV-damaged skin, we prepared a water extract of ginger rhizomes and examined the effects of Z. officinale, gingerol, and shogaol on cell viability and cytokine/chemokine production in UV-irradiated HaCaT cells. We also investigated the in vivo relevance of these findings in C57BL/6 mice using hematoxylin and eosin staining and cytokine measurements. A water extract of Z. officinale, gingerol, and shogaol inhibited production of cytokines in UVB-irradiated HaCaT cells effectively. Treatment with Z. officinale attenuated UVB-induced hyperplasia, infiltration of leukocytes, and dilation of blood vessels in the dermis of mice. Z. officinale, gingerol, and shogaol show potential as anti-inflammatory agents to protect skin against UVB irradiation damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20521990     DOI: 10.1089/jmf.2009.1239

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  8 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

Review 2.  Natural agents: cellular and molecular mechanisms of photoprotection.

Authors:  Farrukh Afaq
Journal:  Arch Biochem Biophys       Date:  2010-12-11       Impact factor: 4.013

3.  Traditional Herbal Formula Banhasasim-tang Exerts Anti-Inflammatory Effects in RAW 264.7 Macrophages and HaCaT Keratinocytes.

Authors:  Seong Eun Jin; Hye-Sun Lim; Yeji Kim; Chang-Seob Seo; Sae-Rom Yoo; Hyeun-Kyoo Shin; Soo-Jin Jeong
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-09       Impact factor: 2.629

4.  Direct Analysis in Real Time Mass Spectrometry (DART-MS) Analysis of Skin Metabolome Changes in the Ultraviolet B-Induced Mice.

Authors:  Hye Min Park; Hye Jin Kim; Young Pyo Jang; Sun Yeou Kim
Journal:  Biomol Ther (Seoul)       Date:  2013-11       Impact factor: 4.634

5.  Effects of shokyo (Zingiberis Rhizoma) and kankyo (Zingiberis Processum Rhizoma) on prostaglandin E2 production in lipopolysaccharide-treated mouse macrophage RAW264.7 cells.

Authors:  Toshiaki Ara; Masanori Koide; Hiroyuki Kitamura; Norio Sogawa
Journal:  PeerJ       Date:  2019-09-17       Impact factor: 2.984

6.  Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells.

Authors:  Iris Bischoff-Kont; Tobias Primke; Lea S Niebergall; Thomas Zech; Robert Fürst
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 7.  Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes.

Authors:  Iris Bischoff-Kont; Robert Fürst
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-15

8.  Sargassum fulvellum Protects HaCaT Cells and BALB/c Mice from UVB-Induced Proinflammatory Responses.

Authors:  Chan Lee; Gyu Hwan Park; Eun Mi Ahn; Chan-Ik Park; Jung-Hee Jang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-09       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.